FROM CONVENTIONAL TO COMPLEMENTARY: PHYTOTHERAPY IN LUNG CANCER MANAGEMENT
AbstractLung cancer, which is primarily caused by smoking tobacco products, environmental pollutants, and genetic predispositions, continues to be ranked among the biggest contributors of cancer-related death worldwide. Numerous sophisticated cancer treatment methods are inefficient because of metastatic spread and susceptibility to traditional anti-cancer medications. Natural therapeutic compounds developed from plants are presently of considerable curiosity because of their excellent absorption and lack of side effects. Relevant instances involve ginsenosides (from ginseng), curcumin (from Curcuma longa), resveratrol (from grapes), and epigallocatechin gallate (from green tea). These compounds all alter important molecular pathways linked to the growth of lung cancer including NF-κB, STAT3, MAPK, and PI3K/Akt signalling. This article highlights the molecular understandings, experimental evidence, and fresh clinical data that support the utilization of natural products effective adjuvant and chemo preventive therapy for lung cancer.
Article Information
1
512-528
890 KB
5
English
IJP
Pushpendra Kumar, Umakant Sahu, Harkesh Dadsena, Chhavi Rahangdale, Lokprabha Hirwani, Bhoomika Swarnkar, Abhishek Nand, Helina Tondan, Yashika Israni and Vishal Jain *
Department of Pharmacognosy, University Institute of Pharmacy, Pt. Ravishankar Shuka University, Raipur, Chhattisgarh, India
vishaljain123@gmail.com
03 May 2026
15 May 2026
26 May 2026
10.13040/IJPSR.0975-8232.IJP.13(6).512-28
01 June 2026
Download